chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client received third hepatitis b vaccine in the afternoon of Thursday, February 6, 2003. No s/s illness at that time. (Two previous vaccines given at private MD office with no reported adverse effects on 8/1/02 and 9/26/02) Mother reports that at approximately 1AM on Sunday morning, February 9, patient thought that she was calling out to mother and "could not get up" and lost continence.  Moments later when she could get up, she was flushed and crying and went to awake mother.  Mother says patient was frightened by episode.  Temperature was "normal" at that time per mother's report.  Later that day, temperature was up to 101-102 degrees.  Child was taken to the doctor (? when) and dr. said it may be the flu or a seizure.  When mother called Public Health Nursing office to report this (on Monday, 2/10/03), patient had been to the doctor and was now exhibiting "head cold" (per mother's report) symptoms (clear runny nose, fever 102 degrees, nausea). On March 3, 2003, follow up phone call to mother was made.  Mother reports that patient is fine, although she was absent from school for a week following the hepatitis b vaccine.  She continued to have a fever for a week and dr. thought it was a viral illness, per mother's report.
Information has been received from a registered nurse (RN) concerning a 14 month old male with allergies to eggs, milk and peanuts, severe eczema and asthma who on 10-FEB-2003 was vaccinated in the right leg with 0.5cc of varicella virus vaccine live (lot 640554/0800M). Concomitant therapy included albuterol and budesonide (PULMICORT). The RN reported that on 26-FEB-2003, the patient developed a maculopapular rash characterized by 10 lesions on his left arm and chest. The patient's maximum temperature was noted to be 97. On that same day, a scab speciment was obtained form the patient. On 03-MAR-2003, the scab specimen was sent to a laboratory for PCR analysis. It was noted that the patient did not have a recent exposure to chickenpox or shingles. Unspecified medical attention was sought. Subsequently, the patient recovered from the maculopapular rash. Results from PCR analysis are as followed: A scab specimen was observed. Varicella zoster virus (VZV) DNA was not amplified. B-globuin DNA was amplified. Interpretation: Adequate specimen, no VZV wild-type strain or vaccine strain virus identified: negative. Additional information is not expected.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 4/21/2021 and 5/18/2021. Patient admitted on 7/31/2021 for cardiogenic shock complicated by acute renal failure, coagulopathy and acute respiratory failure. To assist in management of the cardiogenic shock pt was placed on axillary IABP and dobutamine for inotropic support. Pt was decongested with combination of aquadex and diuretics with improvement in filling conditions. Unfortunately, patient developed persistent fever on 8/11 and was placed on broad spectrum antibiotics, ID was consulted and underwent extensive infectious evaluation.She did have MRSA in pneumonia PCR and candida albicans has grown in urine culture. On 8/16/21 morning pt decompensated hemodynamicallly requiring levophed and vasopressin and continued evaluation revealed that pt had positive IgM COVID antibodies and it was suspected that pt developed a new COVID infection. She continued to decline over the next 48 hours with worsening hemodynamics and renal function and therefore a dialsysis catheter was placed and pt was started on renal replacement therapy. Family was kept uptodate about the patients clinical status and at this point decided to transition focus of care to comfort. Pt then expired the morning of 8/18/21.
This spontaneous report was received from a nurse and refers to unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions, drug reactions and allergies was reported. On 21-APR-2015, the patients were vaccinated with doses of GARDASIL (dose, route of administration, anatomical location, lot# and expiration date were not reported), which were exposed to temperatures outside of the recommended range. No adverse events were reported. This is one of the several reports received from the same source. Additional information has been requested.
swelling on face and neck ; redness on face ; heart beats fast and changed ; pulse slow ; headache ; dizzy ; hot by left side of chest ; oversensitive to touch on mid chest by sternum ; joints ached in hands and feet ; esophagus over sensitive
Chills, no fever. On 11/15/2016 at 7 AM i experienced severe positional vertigo and constant nausea.  It was severe for 12 hours, and slowly subsided.  I am now 72 hours out and almost back to normal.
GRAVIDA 1 PARA 0 26 WEEK GESTATION RECEIVED SEASONAL FLU 9/17/2009.  HAD FLU LIKE SYMPTOMS START 10/9.  CALLED DOCTOR AND RECEIVED TAMIFLU, COUGH MED AND Z-PAK.  RECEIVED H1N1 10/21/2009.  WENT INTO LABOR 10/24/2009.  C-SECTION DONE.  DOCTOR FELT LIKE IT WAS FROM A WEAK CERVIX.  10/28/09 Medical records received for DOS 10/9-10/24. Office notes and ED H&P.  Promigravida at 26 weeks. Developed cramping/abd pain post upper resp/ILI infection (cough, chest cong) and vaccine. Some vag bleeding.  Fully dialted. Intact membranes bulging. fetal heart tones at 140. Footling breech. Emergency c-section w/o complication. Post c-section small amt green incisional d/c noted. No fever. 10/30/2009 received hospital records stating baby boy born per emergency C-section at 26 wks gestation on 10/24/2009. Baby with low Apgar scores, in respiratory distress, initially bagged and then intubated and vent dependent. PE noted chest with retractions, rales throughout lungs. Dx RDS, after stabilized  baby tranferred to another facility to NICU.
Information has been received from a consumer concerning her son who was vaccinated with a dose of ATTENUVAX vaccine (Enders-Edmonston) last year and subsequently his arm swelled. The reporter called to check available of mumps vaccine. No further information is available.
Patient received MMRV injection on 8/29/06 in right deltoid.  On 9/06/06, patient had a vesicular-like rash as reported by her mother.  Rash was on patient's stomach and right thigh.  Patient's mother has been treating the rash with antibiotic ointment. As of this date, the mother says the area on the stomach has improved and is almost completely healed, but the rash on the thigh is still open and requires a light dressing before getting dressed.  No fever noted.
"Modera COVID-19 vaccine EUA" Patient received 0.5 ml instead of 0.25ml COVID booster vaccine.
Redness at injection site, warm and itchy 11 mm x 17 mm after physical exercise.
Experienced symptoms of Benign Paroxysmal Positional Vertigo (BPPV) approximately 36 hours after the 2nd dose of the COVID vaccine. This lasted approximately 48 hours in duration.  I then re-experienced BPPV on day   12 post-shot for a period of approximately 36 hours.
I had a lot of fluid in my ear.  I had a sore throat for the drainage.  These symptoms lasted for about 5 days.  I went the clinic on Nov 11th.  They just checked my ears and throat.
Sore arm 72 hours Headache, fatigue 24-48 hours chills within first six hours
I had my vaccination on 09/09/2022. I started to have symptoms on 11/12/2023 to include with headache and cold like symptoms. I had tremendous aches and pains. I tested COVID-19 positive on 11/15/2022. I contacted my doctor who prescribed molnupiravir. I currently still have red eyes that I experienced during COVID-19 and was diagnosed with Meibomian Gland Dysfunction. I am still under the care of an ophthalmologist. I still have fatigue but I don't know if its from COVID-19 or infection in my glands.
Headache, aches all over body, and joints, fever 99.6F, chills, ear ache.
Atypical trigeminal neuralgia / neuritis Facial pain, tearing, congestion , headache, right side only
soreness at injection site; swelling on arm; redness on arm; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th May 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site pain, swelling arm and erythema of extremities. On an unknown date, the outcome of the injection site pain, swelling arm and erythema of extremities were unknown.   It was unknown if the reporter considered the injection site pain, swelling arm and erythema of extremities to be related to Shingrix.  Additional details were provided as follows: The patient experienced soreness and pain at injection site. The patient was experiencing swelling and redness that was midway down her upper arm as well as just above the bend on her inner arm. The reporter did not consented to follow-up.
Rash around face and chest; bloodshot left eye.  Hydrocortisone cream prescribed by facility APRN on 1/13; skin less red on 1/14 and peeling - no pain or itch.  Dermatology recommendation of Aquaphor for the peeling.
This spontaneous report as received from a consumer refers to a child patient (also reported as friend of a friend's child) of unknown age. No information about medical history, concurrent conditions were reported for the patient. On an unknown date the patient was vaccinated with MMR II (dose strength, route unspecified). No concomitant therapy was reported. On an unknown date the patient experienced autism after receiving MMR II. The outcome of autism is unknown. No product quality complaint was involved. Additional information has been requested.
Chills, low grade fever (99.4), extreme fatigue. Second dose was 1/28/21 at 7:50 a.m., symptoms began 4:30 pm same day lasted all night. Fever broke around 1:00 am on 1/29/21. However fatigue continued throughout most of the day on 1/29/21, and by 4:00 pm 1/29 no more symptoms or fatigue. I took no over the counter medications to counter act the symptoms.
This non-serious medically spontaneous report (initial receipt 02-OCT-2014) concerns a four years and 6 months old male patient. On 26-SEP-2014, the patient received AFLURIA (batch number not provided) 0.5 ml. Outcome was unknown. Reporter's comments: This was discovered during a hospital audit database. The reporter believed the child was fine and he has not returned to the institution.
7 days p/vax in rash w/fever & vomiting; fever lasted 4 days, rash 1 wk + 2 days; had febrile convuls;
Experiencing pain under her armpit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  An adult female patient received bnt162b2 (BNT162B2) (Lot number: EW0164) as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: AXILLARY PAIN (non-serious), outcome "unknown", described as "Experiencing pain under her armpit". Therapeutic measures were taken as a result of axillary pain.   Additional information: She did not have prior vaccination (within 4 weeks). The patient received a Pfizer shot on Thursday and experiencing pain under her armpit. She took Tylenol, 20 minutes ago. The patient's mother was concerned that if she should take her to the emergency room.  No follow-up attempts are possible. No further information is expected.
Heavy bleeding, intense pelvic cramps, vomiting, lightheadedness. Started 4 hours after pfizer vaccine.
Rash on eyelids and arms after 2nd Pfizer COVID vaccine; Rash on eyelids and arms after 2nd Pfizer COVID vaccine; This is a spontaneous report from a contactable consumer via Pfizer sales representative. This consumer (patient's friend) reported for a 65-year-old-male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Solution for injection, Lot number: not reported), dose2 via unspecified route of administration, on an unspecified date (at the age of 65-years-old) as single dose for COVID-19 immunization. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Solution for injection, Lot number: not reported), via unspecified route of administration, on an unspecified date, at a single dose for COVID-19 immunization. The patient's medical history included leukemia as a child and had not had a reaction to a vaccine before. Patient's concomitant medications were not reported. On an unspecified date, the patient experienced rash on eyelids and arms after 2nd Pfizer COVID vaccine. He had been to allergist who provided a steroid cream for arm and said not to put on eyelids. The reporter stated that this occurred close to 3 months ago and still has not resolved. He has a dermatologist appointment on 03Jun2021. The outcome of events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Swollen face, rash on face, feeling very tired, insomnia for 4 days prior to developing rash, rash on hands 6 days after rash on face , joint pain  continuing still now comes and goes in ankle, knee and wrist joints. Swollen glands under arms and in neck for two weeks. Rash was peeling from face after one week.
Within 24 hours post vax, pts upper arm was inflamed and painful around the injection site. Pt seen 48 hours post vax and inflammation around injection site was clearing but arm just above elbow was inflamed, edematous, and tender to palpation.
Patient received full dose (0.5mL) for 4th dose instead of half dose (0.25mL). She was informed on the same date once the error was discovered. She reported no side effects outside of normal/expected first-second day side effects (tiredness, achiness, etc.). She reported no additional side effects after day 2.
Almost immediately after injection was given, patient complained of chest pain, light-headedness and sweating.  He admitted to a previous history with past vaccinations although inconsistently.  Chest pain resolved, per patient.  Patient transported by wheelchair to paramedic area with brief loss of consciousness, spontaneously resolved.  Patient able to transfer from wheelchair to cot, reporting improvement when lying down.  Paramedic and EMT monitored vitals,  paramedic advised transport to hospital to rule out cardiac event, patient consented.  Tranported to Hospital
My sinus infection started on 01/28/2023 in the morning. I had a runny nose, nasal congestion, headaches, and lethargic. I went to a local clinic since my doctor was out of town. The prescribed me antibiotics. I also went to another clinic where they advised me to see my regular doctor since mine was mild they advised me to use over the counter medication such as MUCINEX and ibuprofen. I went to my primary care she said it was viral so she prescribe gabapentin 3 times a day. As of today I still have the symptoms.
Patient's daughter states the patient has a red arm, swollen, and experienced diarrhea and not feeling will starting approximately on Friday
Pfizer Vaccine lot #FJ1620 was affected due to out of temperature range. No adverse reactions from patients.  2 patient's affected.
A report has been received from a Physician concerning a, subject of unknown gender, who had been receiving Nasal FLUMIST Quadrivalent (Intranasal), 0.2 Milliliters, unknown for Influenza. FLUMIST Quadrivalent (Intranasal) started on an unknown date for Influenza. It was stated that the patient received half dose of FLUMIST and she was unable to follow the correct instructions. The outcome of the event of unable to follow correct instructions and 1/2 dose is unknown. The report was considered to be non-serious.
Swelling on neck/clavicle area, on the right side. Area was tender to the touch, soft to the touch. Feels like a lymph node.
wants to sleep all the time even if I had nap; lung area feels a bit sore inside; achy; chills; itchy; red below her injection site; Hypersensitivity reaction; rash on back across lung area and below injection site; Two lumps below her injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), VACCINATION SITE INDURATION (Two lumps below her injection site), VACCINATION SITE ERYTHEMA (red below her injection site), SOMNOLENCE (wants to sleep all the time even if I had nap) and PULMONARY PAIN (lung area feels a bit sore inside) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hay fever, Hives (endorsed allergy history on ADR), Hypersensitivity reaction (NOS) (endorsed allergy history on ADR) and Catheter management (self catharize twice daily) since an unknown date. Concurrent medical conditions included Sulfonamide allergy (had swelling of fingers and lips as adverse reaction) since 1960, Allergy to antibiotic (had rash, stomach upset as adverse reaction) since 2019, Allergy to antibiotic (Had rash as adverse reaction) since 2019, Arrhythmia since 2011 and Incomplete bladder emptying. Concomitant products included APIXABAN (ELIQUIS) from 2018 to an unknown date and METOPROLOL from 2011 to an unknown date for Arrhythmia, CENTRUM VITAMINTS for Routine health maintenance.    On 27-Jan-2021 at 12:10 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PRURITUS (itchy), VACCINATION SITE INDURATION (Two lumps below her injection site), VACCINATION SITE ERYTHEMA (red below her injection site), HYPERSENSITIVITY (Hypersensitivity reaction) and RASH (rash on back across lung area and below injection site). On 16-Feb-2021, the patient experienced SOMNOLENCE (wants to sleep all the time even if I had nap), PULMONARY PAIN (lung area feels a bit sore inside), MYALGIA (achy) and CHILLS (chills). On 06-Feb-2021, PRURITUS (itchy), HYPERSENSITIVITY (Hypersensitivity reaction) and RASH (rash on back across lung area and below injection site) had resolved, VACCINATION SITE INDURATION (Two lumps below her injection site) and VACCINATION SITE ERYTHEMA (red below her injection site) outcome was unknown. At the time of the report, SOMNOLENCE (wants to sleep all the time even if I had nap) outcome was unknown and PULMONARY PAIN (lung area feels a bit sore inside), MYALGIA (achy) and CHILLS (chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment was reported for the events.   This case was linked to MOD-2021-239054 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: includes medical history of allergic reactions and long-standing conditions, updates to concomitant medications, resolution with date.
Patient broke out in hives/rash the day after receiving vaccine in areas of naval, arms, and buttocks. Rash/hives getting better. Although skin is still hypersensitive.
PATIENT FELT SLIGHT DIZZY LESS THAN A MINUTE PATIENT RECOVERED IMMEDIATELY AND WENT HOME. THIS PATIENT ALSO DID NOT HAD ANY FOOD OR LIQUIDS BEFORE VACCINATION. DOCTOR FELT THIS ALSO A VERY MILD VASO VAGAL REACTION.
The following evening pt started itching on LA and found band aide still intact from the vaccine given the previous day. A quarter size redness and swelling at the site of injection with itching was noticed for 3 days. On fourth day almost gone. After nine days the swelling and itchiness re-appeared on LA. Today there is a rectangle shape dull purplish red area with slight edema and no itching.
Information has been received from a physician concerning a 13 year old female with a history of atrial septal defect repair who on 29-AUG-2007 was vaccinated IM with a first dose of Gardasil. On 29-AUG-2007 within 5 minutes post vaccination, the patient fainted. Subsequently, the patient recovered from fainting. The patient then sat up, but then started "seizure like jerking motion". The patient was "kept in the office" for an additional 15 minutes to 20 minutes. The patient then passed out again. The patient was admitted to the emergency room. At the time of the report, the patients status was unknown. Upon internal review, "seizure like jerking motion" was considered to be an other important medical event. Additional information has been requested.
Patient called on 2/13/2018 complaining of pain, swelling, warm to the touch, redness in right arm. She started noticing the symptoms on 2/12/2018 around 8 pm or after. Patient was advised to put a cool cloth or ice bag on arm, take ibuprofen, and monitor. Patient was told to go to urgent care or er if symptoms got worse.
Day 1-3: Fatigue, sore arm Day 4-6: None Day 7-9: Injection site red, swollen and hot, fatigue, vertigo, dizziness, weakness, facial swelling---experiencing now.
Mild case of chicken pox when 4yrs old. Small fluid blisters on face & chest & stomach, back & legs. BENADRYL & AVEENO bath for itchiness.
Pt received VARIVAX and PENTACEL om 8/2/18. Pt developed vesicular rash.
dizziness; clamminess; lost feeling in my arms, wrist; fingers curled; pain at the injection site; Fatigue; bodyaches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled) and VACCINATION SITE PAIN (pain at the injection site) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (Fatigue), MYALGIA (bodyaches) and NAUSEA (Nausea). At the time of the report, DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (Fatigue), MYALGIA (bodyaches) and NAUSEA (Nausea) had not resolved.            No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Pain in the injection site and a flu-like reaction hours later. Chills and soreness that spread through out my body. It was difficult to sleep. This is the second in a series and the first injection had the same effect. I did not know about the reporting agency until informed by my Physician.
1/20/03 Mother noted skin peeling off on tips of fingers, bilateral on both hands, all digits. 1/23/03 Seen in office. Note tips of fingers are red and puffy with evidence of peeling. No blisters, pain, or burning. No fever. None on soles/toes of feet. Note: very small macule/papule type areas in mouth or gums beside tongue. *F/UP report on 4/3/03: Client was seen by pediatrician for evaluation. Dx with dyshidresis. Using Triamencalone .025% cream on fingers. Mother states is stress related immune response to some component of vaccine.